The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
Open accessAbstract
BACKGROUND: The options for secondary prevention of cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medications or percutaneous closure of the patent foramen ovale. We investigated whether closure is superior to medical therapy. METHODS: We performed a multicenter, superiority trial in 29 centers in Europe, Canada, Brazil, and Australia in which the assessors of end points were unaware of the study-group assignments. Patients with a patent foramen ovale and ischemic stroke, transient ischemic attack (TIA), or a peripheral thromboembolic event were randomly assigned to undergo closure of the patent foramen ovale with the Amplatzer PFO Occluder or to receive medical therapy. The primary end point was a composite of death, nonfatal stroke, TIA, or peripheral embolism. Analysis was performed on data for the intention-to-treat population. RESULTS: The mean duration of follow-up was 4.1 years in the closure group and 4.0 years in the medical-therapy group. The primary end point occurred in 7 of the 204 patients (3.4%) in the closure group and in 11 of the 210 patients (5.2%) in the medical-therapy group (hazard ratio for closure vs. medical therapy, 0.63; 95% confidence interval [CI], 0.24 to 1.62; P=0.34). Nonfatal stroke occurred in 1 patient (0.5%) in the closure group and 5 patients (2.4%) in the medical-therapy group (hazard ratio, 0.20; 95% CI, 0.02 to 1.72; P=0.14), and TIA occurred in 5 patients (2.5%) and 7 patients (3.3%), respectively (hazard ratio, 0.71; 95% CI, 0.23 to 2.24; P=0.56). CONCLUSIONS: Closure of a patent foramen ovale for secondary prevention of cryptogenic embolism did not result in a significant reduction in the risk of recurrent embolic events or death as compared with medical therapy. (Funded by St. Jude Medical; ClinicalTrials.gov number, NCT00166257.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Self-citationEaston, J. D., Saver, J. L., Albers, G. W., Alberts, M. J., Chaturvedi, S., Feldmann, E., Hatsukami, T. S., Higashida, R. T., Johnston, S. C., Kidwell, C. S., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.192218 · Cited by 1,845
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Furlan, A. J., Reisman, M., Massaro, J., Mauri, L., Adams, H., Albers, G. W., Felberg, R., Herrmann, H., Kar, S., Landzberg, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1009639 · Cited by 1,060
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
Carroll, J. D., Saver, J. L., Thaler, D. E., Smalling, R. W., Berry, S., MacDonald, L. A., Marks, D. S., & Tirschwell, D. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301440 · Cited by 983
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism.
Bridges, N. D., Hellenbrand, W. E., Latson, L., Filiano, J. J., Newburger, J. W., & Lock, J. E. (1992) · Circulation · doi:10.1161/01.cir.86.6.1902 · Cited by 473
Stroke recurrence in patients with patent foramen ovale: The Lausanne Study
Bogousslavsky, J., Garazi, S., Jeanrenaud, X., Aebischer, N., & Van Melle, G. (1996) · Neurology · doi:10.1212/wnl.46.5.1301 · Cited by 416
Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic?
Alsheikh-Ali, A. A., Thaler, D. E., & Kent, D. M. (2009) · Stroke · doi:10.1161/strokeaha.109.547828 · Cited by 378
Agarwal, S., Bajaj, N. S., Kumbhani, D. J., Tuzcu, E. M., & Kapadia, S. R. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.02.021 · Cited by 195
Wahl, A., Jüni, P., Mono, M.-L., Kalesan, B., Praz, F., Geister, L., Räber, L., Nedeltchev, K., Mattle, H. P., Windecker, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.030494 · Cited by 188
Self-citationPatent Foramen Ovale in Young Adults with Unexplained Stroke
Kizer, J. R., & Devereux, R. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp043981 · Cited by 183
Devuyst, G., Bogousslavsky, J., Ruchat, P., Jeanrenaud, X., Despland, P.-A., Regli, F., Aebischer, N., Karpuz, H. M., Castillo, V., Guffi, M., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1162 · Cited by 162
Kitsios, G. D., Dahabreh, I. J., Dabrh, A. M. A., Thaler, D. E., & Kent, D. M. (2011) · Stroke · doi:10.1161/strokeaha.111.631648 · Cited by 148
Kutty, S., Sengupta, P. P., & Khandheria, B. K. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.085 · Cited by 136
Cardiogenic and Aortogenic Brain Embolism
Doufekias, E., Segal, A. Z., & Kizer, J. R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.053 · Cited by 130
Ruchat, P. (1997) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(97)01175-5 · Cited by 75
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention
O’Gara, P. T., Messe, S. R., Tuzcu, E. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192272 · Cited by 61
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Metadata
- Authors
- Meier, B., Kalesan, B., Mattle, H. P., Khattab, A. A., Hildick-Smith, D., Dudek, D., Andersen, G., Ibrahim, R., Schuler, G., Walton, A. S., Wahl, A., Windecker, S., & Jüni, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-21
- Volume
- 368
- Issue
- 12
- Pages
- 1083-1091
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2103945128
- Cited by
- 920
- References
- 16
- FWCI
- 79.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.